NEW YORK (GenomeWeb News) – The Parisian genomic testing company Genomic Vision said today that it has raised €4 million ($6.3 million) in a round of Series B financing from one new and one previous investor.
 
The new backer, Vesalius BioCapital, joined Society Generale Asset Management Alternative Investments in providing the funding.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.